Sign up to save your podcasts
Or
Share Swiss Re’s Kelly: How Behavioral Science Is Key to Potential of GLP-1 Medications
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Swiss Re’s Kelly: How Behavioral Science Is Key to Potential of GLP-1 Medications
Natalie Kelly, head of life & health global underwriting, Swiss Re, explains why long-term health benefits from blood sugar regulators also depend on sustained behavior change, personalized underwriting and the strategic use of behavioral science.
View all episodes
By AM Best Company
4.8
88 ratings
Natalie Kelly, head of life & health global underwriting, Swiss Re, explains why long-term health benefits from blood sugar regulators also depend on sustained behavior change, personalized underwriting and the strategic use of behavioral science.
More shows like AM Best Audio Podcast
View all
WSJ What’s News
4,334 Listeners
The Glenn Show
2,251 Listeners
Podcasts - Insurance Journal
23 Listeners
InsTech - insurance & innovation with Matthew Grant & Robin Merttens
10 Listeners
Wall Street Breakfast
1,018 Listeners
The Journal.
5,907 Listeners
Actuary Voices
12 Listeners
The Ezra Klein Show
15,206 Listeners
Business Breakdowns
343 Listeners
The Reinsurance Podcast
10 Listeners